Combining Checkpoint and Tyrosine Kinase Inhibitor in the Treatment of Renal Cell Carcinoma

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [21] Severe cardiomyopathy in a patient with renal cell carcinoma after treatment with the novel tyrosine kinase inhibitor sunitinib
    Chorianopoulos, E.
    Jager, D.
    Katus, H. A.
    Frey, N.
    CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (11) : 829 - 830
  • [22] Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
    Brookman-May, Sabine
    May, Matthias
    Gilfrich, Christian
    Wieland, Wolf Ferdinand
    Burger, Maximilian
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (06) : 813 - 823
  • [23] TREATMENT OF RENAL CARCINOMA IN A BINTURONG (ARCTICTIS BINTURONG) WITH NEPHRECTOMY AND A TYROSINE KINASE INHIBITOR
    Thompson, Kimberly A.
    Patterson, Jon
    Fitzgerald, Scott D.
    Needle, David
    Harrison, Tara
    JOURNAL OF ZOO AND WILDLIFE MEDICINE, 2016, 47 (04) : 1109 - 1113
  • [24] Pazopanib: An Oral Multitargeted Tyrosine Kinase Inhibitor for Use in Renal Cell Carcinoma
    LaPlant, Kourtney D.
    Louzon, Paige D.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (06) : 1054 - 1060
  • [25] Tyrosine kinase inhibitor sunitinib targets the vasculature of clear cell renal cell carcinoma: a morphometrical study of treatment effect
    Chen, Lu
    Chen, Longwen
    Huang, Jie
    Xu, Danfeng
    Wang, Linhui
    Zhou, Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (03): : 3571 - 3578
  • [26] Developments in the use of tyrosine kinase inhibitors in the treatment of renal cell carcinoma
    Reed, Jarred P.
    Posadas, Edwin M.
    Figlin, Robert A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (03) : 259 - 271
  • [27] Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma
    Wang, Jiajun
    Xu, Xianglai
    Wang, Ying
    Zhu, Yanjun
    CELLULAR ONCOLOGY, 2025,
  • [28] Tyrosine kinase inhibitors in renal cell carcinoma
    Potti, A
    George, DJ
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6371S - 6376S
  • [29] Ongoing Screening and Treatment to Potentially Reduce Tyrosine Kinase Inhibitor-Related Fatigue in Renal Cell Carcinoma
    Anand, Deepa
    Escalante, Carmen P.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 50 (01) : 108 - 117
  • [30] Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report
    Azuma, Takeshi
    Sugihara, Tohru
    Honda, Sachi
    Yoshizaki, Uran
    Nimi, Fusako
    Tsuru, Ibuki
    Kume, Haruki
    ONCOLOGY LETTERS, 2019, 17 (04) : 4011 - 4015
12345